POLE proofreading mutation, immune response and prognosis in endometrial cancer by Van Gool, I, Bosse, T, Church, D

Neoepitopes and CD3-positive and CD8-positive cells in polymerase e-mutated and microsatellite-instable endometrial cancers by van Gool, I, Bosse, T, Church, D

A panoply of errors: polymerase proofreading domain mutations in cancer by Rayner, E, Van Gool, I, Palles, C, Kearsey, S, Bosse, T, Tomlinson, I, Church, D

Prognostic benefit of POLE exonuclease domain mutations in endometrial cancer cannot be explained by increased sensitivity to adjuvant treatment strategies by Van Gool, I, Rayner, E, Osse, E, Tomlinson, I, Smit, V, Creutzberg, C, Church, D, de Wind, N, Bosse, T, Drost, M

Adjuvant treatment for POLE proofreading domain-mutant cancers: sensitivity to radiotherapy, chemotherapy, and nucleoside analogues by Van Gool, I, Rayner, E, Osse, E, Nout, R, Creutzberg, C, Tomlinson, I, Church, D, Smit, V, de Wind, N, Bosse, T, Drost, M

Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibitio... by Eggink, F, Van Gool, I, Leary, A, Pollock, P, Crosbie, E, Mileshkin, L, Jordanova, E, Adam, J, Freeman-Mills, L, Church, D, Creutzberg, C, De Bruyn, M, Nijman, H, Bosse, T

POLE proofreading mutations elicit an anti-tumor immune response in endometrial cancer by Klenerman, P, Church, D, Tomlinson, I, van Gool, I, Eggink, F, Freeman-Mills, L, Stelloo, E, Marchi, E, de Bruyn, M, Palles, C, Nout, R, de Kroon, C, Osse, E, Creutzberg, C, Smit, V, Nijman, H, Bosse, T

A transcriptionally distinct CXCL13+ CD103+ CD8+ T-cell population is associated with B-cell 2 recruitment and neoantigen load in human cancer by Workel, H, Lubbers, J, Arnold, R, Prins, T, Van Der Vlies, P, De Lange, K, Bosse, T, Van Gool, I, Eggink, F, Wouters, M, Komdeur, F, Creutzberg, C, Kol, A, Plat, A, Glaire, M, Church, D, Nijman, H, De Bruyn, M